Filing Details
- Accession Number:
- 0001127602-10-001437
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-12 12:00:00
- Reporting Period:
- 2010-01-11
- Filing Date:
- 2010-01-12
- Accepted Time:
- 2010-01-12 16:26:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1278042 | A Mark Goldberg | Parexel International Corporation 195 West Street Waltham MA 02451 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-01-11 | 5,000 | $8.55 | 125,339 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-01-11 | 5,000 | $17.00 | 120,339 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-11 | 1,174 | $16.00 | 119,165 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-11 | 1,174 | $17.00 | 117,991 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-01-11 | 5,000 | $0.00 | 5,000 | $8.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000 | 2012-01-27 | No | 4 | M | Direct |
Footnotes
- The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person.
- Currently Exercisable.